KLRA Smart Money
Kailera Therapeutics, Inc.
1W: +1.9%
1M: +18.1%
3M: -22.2%
YTD: -49.5%
$13.13
+0.36 (+2.82%)
Weekly Expected Move ±13.3%
$9
$11
$13
$15
$16
Credit Risk of going bust: not rated Debt: 0.6% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026102
Institutions Holding
+0 vs prior
147.2%
Ownership
+147.17%
102
New
0
Increased
0
Reduced
0
Closed
👔 Insider Trades
18 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-20 | Kaplan Andrew T. | director | P-Purchase | 8,398,438 | $16.00 | $134.4M | Filing |
| 2026-04-20 | BAIN CAPITAL INVESTORS LLC | 10% owner | P-Purchase | 8,398,438 | $16.00 | $134.4M | Filing |
| 2026-04-20 | Bain Capital XIV General Partner, LLC | 10% owner | P-Purchase | 8,398,438 | $16.00 | $134.4M | Filing |
| 2026-04-20 | Bain Capital Fund XIV, L.P. | 10% owner | P-Purchase | 8,398,438 | $16.00 | $134.4M | Filing |
| 2026-04-20 | BCPE Perseus Investor GP, LLC | 10% owner | P-Purchase | 8,398,438 | $16.00 | $134.4M | Filing |
| 2026-04-20 | BCPE Perseus Investor, LP | 10% owner | P-Purchase | 8,398,438 | $16.00 | $134.4M | Filing |
| 2026-04-20 | Koppel Adam | director | P-Purchase | 1,562,500 | $16.00 | $25.0M | Filing |
| 2026-04-20 | Bain Capital Life Sciences Investors, LLC | 10% owner | P-Purchase | 1,562,500 | $16.00 | $25.0M | Filing |
| 2026-04-20 | Bain Capital Life Sciences IV General Partner, LLC | 10% owner | P-Purchase | 1,562,500 | $16.00 | $25.0M | Filing |
| 2026-04-20 | Bain Capital Life Sciences Fund IV, L.P. | 10% owner | P-Purchase | 1,562,500 | $16.00 | $25.0M | Filing |
| 2026-04-20 | BCLS Fund IV Investments GP, LLC | 10% owner | P-Purchase | 1,562,500 | $16.00 | $25.0M | Filing |
| 2026-04-20 | BCLS Fund IV Investments, L.P. | 10% owner | P-Purchase | 1,562,500 | $16.00 | $25.0M | Filing |
| 2026-04-20 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% owner | C-Conversion | 9,477,719 | $— | $0 | Filing |
| 2026-04-20 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% owner | C-Conversion | 2,034,133 | $— | $0 | Filing |
| 2026-04-20 | RTW INVESTMENTS, LP | 10% owner | C-Conversion | 10,276,820 | $— | $0 | Filing |
| 2026-04-20 | WONG RODERICK | 10% owner | C-Conversion | 10,276,820 | $— | $0 | Filing |
| 2026-04-20 | RTW INVESTMENTS, LP | 10% owner | P-Purchase | 500,000 | $16.00 | $8.0M | Filing |
| 2026-04-20 | WONG RODERICK | 10% owner | P-Purchase | 500,000 | $16.00 | $8.0M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Bain Capital Investors LLC | 26,255,581 | $578M | +26,255,581 | 2026-06-30 | Filing |
| Bain Capital Life Sciences Investors, LL | 22,583,268 | $498M | +22,583,268 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 10,776,820 | $237M | +10,776,820 | 2026-06-30 | Filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 7,304,688 | $161M | +7,304,688 | 2026-06-30 | Filing |
| Atlas Venture Life Science Advisors, LLC | 5,171,282 | $114M | +5,171,282 | 2026-06-30 | Filing |
| FMR LLC | 3,970,865 | $87M | +3,970,865 | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,928,604 | $87M | +3,928,604 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 3,240,787 | $71M | +3,240,787 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,208,286 | $71M | +3,208,286 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2,919,110 | $64M | +2,919,110 | 2026-06-30 | Filing |
| Royalty Pharma Sub-Manager, LLC | 2,455,357 | $54M | +2,455,357 | 2026-06-30 | Filing |
| Siren, L.L.C. | 2,214,286 | $49M | +2,214,286 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,693,958 | $37M | +1,693,958 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,652,507 | $36M | +1,652,507 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,133,115 | $25M | +1,133,115 | 2026-06-30 | Filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1,100,000 | $24M | +1,100,000 | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 1,100,000 | $24M | +1,100,000 | 2026-06-30 | Filing |
| Trails Edge Capital Partners, LP | 984,786 | $22M | +984,786 | 2026-06-30 | Filing |
| UBS Group AG | 972,683 | $21M | +972,683 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 970,857 | $21M | +970,857 | 2026-06-30 | Filing |